ketoconazole has been researched along with Opportunistic Infections in 53 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Opportunistic Infections: An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A patient with AIDS presented with a fever, shortness of breath and a productive cough." | 5.28 | Disseminated histoplasmosis in an AIDS patient treated with itraconazole. ( Barton, SE; Gazzard, BG; Kell, PD; Midgley, J; Samarasinghe, PL; Smith, DE, 1991) |
| " Treatment of invasive aspergillosis required a higher dosage (about 5 mg/kg) and prolonged administration." | 5.28 | Experience with itraconazole in cryptococcosis and aspergillosis. ( Almaviva, M; Cristina, S; De Maria, R; Ferrazzi, P; Fiocchi, R; Langer, M; Negri, C; Scoccia, S; Tortorano, AM; Viviani, MA, 1989) |
| "Fluconazole was 5-20-fold more active than ketoconazole against systemic aspergillosis and against systemic, intracranial and pulmonary cryptococcosis but was less active than amphotericin B." | 5.27 | Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice. ( Andrews, RJ; Marriott, MS; Richardson, K; Troke, PF, 1987) |
| "The recently developed antifungal agents itraconazole and fluconazole have been evaluated for primary and maintenance therapy for mycoses in patients with acquired immune deficiency syndrome (AIDS) in comparative and non-comparative trials." | 5.07 | Opportunistic fungal infections in patients with acquired immune deficiency syndrome. ( Viviani, MA, 1992) |
| "To determine the efficacy and toxicity of two systemically active antifungal agents in the treatment of buccal and oesophageal candidiasis 111 HIV-infected patients with microscopically-confirmed candidiasis were randomized to receive either 200 mg itraconazole once a day or 200 mg ketoconazole twice a day for 28 days in a double blind study." | 5.07 | Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV. ( Allan, M; Connolly, GM; Gazzard, BG; Midgley, J; Smith, DE, 1991) |
| "Zidovudine dosage was adjusted 92 times in the other 31 children (52%), mostly due to neutropenia (83%)." | 2.67 | Low-dose zidovudine in children with an human immunodeficiency virus type 1 infection acquired in the perinatal period. ( Blanche, S; Debré, M; Duliege, AM; Griscelli, C; Kouzan, S; Navarette, MS; Rouzioux, C; Seldrup, J; Tardieu, M, 1991) |
| "We present another case of infectious spondylodiscitis due to B." | 2.45 | Spondylodiscitis due to an emergent fungal pathogen: Blastoschizomyces capitatus, a case report and review of the literature. ( Celik, AD; Kantarcioglu, S; Mert, A; Ozaras, R; Ozturk, R; Tabak, F, 2009) |
| "Zygomycosis is an opportunistic fungal infection that is increasingly reported in hematological patients." | 2.42 | Improved outcome of zygomycosis in patients with hematological diseases? ( Anagnostopolous, I; Gleissner, B; Schilling, A; Siehl, I; Thiel, E, 2004) |
| "I have tried to use the AIDS commentaries to keep up with these advances." | 2.38 | Azoles and AIDS. ( Larsen, RA, 1990) |
| "Systemic candidiasis is a disease of increasing incidence and proportions, which appears to be associated with the advances in modern medicine." | 2.38 | Systemic candidiasis. ( Ray, TL, 1989) |
| "Fusarium solani was reported as the agent of a cutaneous infection in an injured sea turtle collected in the Mediterranean Sea." | 1.30 | Cutaneous hyalohyphomycosis caused by Fusarium solani in a loggerhead sea turtle (Caretta caretta L.). ( Alegre, F; Alonso, JM; Cabañes, FJ; Castellá, G; Domingo, M; Pont, S, 1997) |
| "Three patients with AIDS had an intensely pruritic eosinophilic pustular folliculitis associated with abundant Pityrosporum yeasts in the follicles, demonstrated by direct microscopy." | 1.28 | Eosinophilic pustular folliculitis in patients with acquired immunodeficiency syndrome. ( Barranco, JC; Clotet, B; Ferrándiz, C; Lorenzo, JC; Ribera, M, 1992) |
| "A patient with AIDS presented with a fever, shortness of breath and a productive cough." | 1.28 | Disseminated histoplasmosis in an AIDS patient treated with itraconazole. ( Barton, SE; Gazzard, BG; Kell, PD; Midgley, J; Samarasinghe, PL; Smith, DE, 1991) |
| "Viral esophagitis was identified in 13 cases (eight herpes simplex virus and five cytomegalovirus), and an esophagitis of unknown origin was documented in two patients." | 1.28 | Opportunistic infections of the esophagus not responding to oral systemic antifungals in patients with AIDS: their frequency and treatment. ( Bianchi Porro, G; Cernuschi, M; Lazzarin, A; Parente, F; Rizzardini, G; Valsecchi, L, 1991) |
| " In order to prevent a mycotic infection in these immunocompromised patients, itraconazole, a new broad-spectrum antimycotic drug of the azole group, was given in an oral dosage of 100 mg day-1 (mean duration of prophylactic treatment 24 months)." | 1.28 | Prophylaxis of fungal infections with itraconazole in immunocompromised cancer patients. ( König, HJ; Mühldorfer, SM, 1990) |
| " Treatment of invasive aspergillosis required a higher dosage (about 5 mg/kg) and prolonged administration." | 1.28 | Experience with itraconazole in cryptococcosis and aspergillosis. ( Almaviva, M; Cristina, S; De Maria, R; Ferrazzi, P; Fiocchi, R; Langer, M; Negri, C; Scoccia, S; Tortorano, AM; Viviani, MA, 1989) |
| "Fluconazole was 5-20-fold more active than ketoconazole against systemic aspergillosis and against systemic, intracranial and pulmonary cryptococcosis but was less active than amphotericin B." | 1.27 | Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice. ( Andrews, RJ; Marriott, MS; Richardson, K; Troke, PF, 1987) |
| "This study assessed the potential pharmacokinetic interaction between rifampicin and ketoconazole, two drugs used to treat the increasingly common combination of Mycobacterium tuberculosis and Candida albicans infection in AIDS patients." | 1.27 | Pharmacokinetic study of the interaction between rifampicin and ketoconazole. ( Doble, N; Keal, EE; Lush, M; Rowland-Hill, C; Shaw, R; Warnock, DW, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (22.64) | 18.7374 |
| 1990's | 32 (60.38) | 18.2507 |
| 2000's | 5 (9.43) | 29.6817 |
| 2010's | 4 (7.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Razouk, S | 1 |
| Sebbani, S | 1 |
| Agoumi, A | 1 |
| Benouchen, T | 1 |
| Malihi, A | 1 |
| Nacir, A | 1 |
| Abouhafsse, A | 1 |
| Al Hamany, Z | 1 |
| Tligui, H | 1 |
| Seneviratne, CJ | 1 |
| Fong, PH | 1 |
| Wong, SS | 1 |
| Lee, VH | 1 |
| Celik, AD | 1 |
| Ozaras, R | 1 |
| Kantarcioglu, S | 1 |
| Mert, A | 1 |
| Tabak, F | 1 |
| Ozturk, R | 1 |
| Paul, AE | 1 |
| Mansfield, CS | 1 |
| Thompson, M | 1 |
| Gabalec, F | 1 |
| Zavrelová, A | 1 |
| Havel, E | 1 |
| Cerman, J | 1 |
| Radocha, J | 1 |
| Svilias, I | 1 |
| Cáp, J | 1 |
| Silva, V | 1 |
| Zepeda, G | 1 |
| Alvareda, D | 1 |
| Gleissner, B | 1 |
| Schilling, A | 1 |
| Anagnostopolous, I | 1 |
| Siehl, I | 1 |
| Thiel, E | 1 |
| Oosterhuis, JK | 1 |
| van den Berg, G | 1 |
| Monteban-Kooistra, WE | 1 |
| Ligtenberg, JJ | 1 |
| Tulleken, JE | 1 |
| Meertens, JH | 1 |
| Zijlstra, JG | 1 |
| Watt, PR | 1 |
| Robins, GM | 1 |
| Galloway, AM | 1 |
| O'Boyle, DA | 1 |
| Shaw, GS | 1 |
| Ramos, EL | 1 |
| Bécherel, PA | 1 |
| Chosidow, O | 1 |
| Francés, C | 1 |
| Goldberg, SL | 1 |
| Geha, DJ | 1 |
| Marshall, WF | 1 |
| Inwards, DJ | 1 |
| Hoagland, HC | 1 |
| Rosen, T | 1 |
| Rinaldi, MJ | 1 |
| Tschen, JA | 1 |
| Stern, JK | 1 |
| Cernoch, P | 1 |
| Cabañes, FJ | 1 |
| Alonso, JM | 1 |
| Castellá, G | 1 |
| Alegre, F | 1 |
| Domingo, M | 1 |
| Pont, S | 1 |
| Grunwald, MH | 1 |
| Cagnano, M | 1 |
| Mosovich, M | 1 |
| Halevy, S | 1 |
| Ellepola, AN | 1 |
| Samaranayake, LP | 1 |
| Lafeuillade, A | 1 |
| Chaffanjon, P | 1 |
| Delbeke, E | 1 |
| Quilichini, R | 1 |
| de Gans, J | 2 |
| Portegies, P | 1 |
| Tiessens, G | 1 |
| Eeftinck Schattenkerk, JK | 2 |
| van Boxtel, CJ | 1 |
| van Ketel, RJ | 2 |
| Stam, J | 1 |
| Supparatpinyo, K | 1 |
| Chiewchanvit, S | 1 |
| Hirunsri, P | 1 |
| Uthammachai, C | 1 |
| Nelson, KE | 1 |
| Sirisanthana, T | 1 |
| Viviani, MA | 3 |
| Eloy, O | 1 |
| Joly, V | 1 |
| Ghnassia, JC | 1 |
| Carbon, C | 1 |
| Yeni, P | 1 |
| McGinnis, MR | 1 |
| Campbell, G | 1 |
| Gourley, WK | 1 |
| Lucia, HL | 1 |
| Ferrándiz, C | 1 |
| Ribera, M | 1 |
| Barranco, JC | 1 |
| Clotet, B | 1 |
| Lorenzo, JC | 1 |
| Lewis, MA | 1 |
| Samaranyake, LP | 1 |
| Lamey, PJ | 1 |
| Kell, PD | 1 |
| Smith, DE | 2 |
| Barton, SE | 1 |
| Midgley, J | 2 |
| Samarasinghe, PL | 1 |
| Gazzard, BG | 2 |
| Allan, M | 1 |
| Connolly, GM | 1 |
| Andreo, JA | 1 |
| Vivancos, F | 1 |
| Serrano, P | 1 |
| Soriano, J | 1 |
| Angeli, A | 1 |
| Masera, RG | 1 |
| Gatti, G | 1 |
| Yee, RW | 1 |
| Tio, FO | 1 |
| Martinez, JA | 1 |
| Held, KS | 1 |
| Shadduck, JA | 1 |
| Didier, ES | 1 |
| Sauri, MA | 1 |
| Julie, NL | 1 |
| Juarbe, HM | 1 |
| Mayo, FJ | 1 |
| Ligon, CH | 1 |
| Fox, RL | 1 |
| Koss, G | 1 |
| Coggin, JT | 1 |
| Burbach, JW | 1 |
| Barton, JH | 1 |
| Blanche, S | 1 |
| Duliege, AM | 1 |
| Navarette, MS | 1 |
| Tardieu, M | 1 |
| Debré, M | 1 |
| Rouzioux, C | 1 |
| Seldrup, J | 1 |
| Kouzan, S | 1 |
| Griscelli, C | 1 |
| Parente, F | 1 |
| Cernuschi, M | 1 |
| Rizzardini, G | 1 |
| Lazzarin, A | 1 |
| Valsecchi, L | 1 |
| Bianchi Porro, G | 1 |
| Pierard, GE | 1 |
| Pierard-Franchimont, C | 1 |
| Rurangirwa, A | 1 |
| Hermanns, G | 1 |
| Dokekias, A | 1 |
| de Beule, D | 1 |
| Fillet, G | 1 |
| Lamprecht, J | 1 |
| Kühn, AG | 1 |
| Sauer, S | 1 |
| Larsen, RA | 1 |
| Denning, DW | 1 |
| Tucker, RM | 1 |
| Hanson, LH | 1 |
| Stevens, DA | 1 |
| Mühldorfer, SM | 1 |
| König, HJ | 1 |
| Lin-Greenberg, A | 1 |
| Villacin, A | 1 |
| Moussa, G | 1 |
| Meiteles, LZ | 1 |
| Lucente, FE | 1 |
| Hunziker, UA | 1 |
| Nadal, D | 1 |
| Jendis, JB | 1 |
| Tomasik, Z | 1 |
| Wetzel, JC | 1 |
| Schüpbach, J | 1 |
| Seger, RA | 1 |
| Kaben, U | 1 |
| Westphal, HJ | 1 |
| Zimmermann, R | 1 |
| Dunker, H | 1 |
| Tortorano, AM | 1 |
| Langer, M | 1 |
| Almaviva, M | 1 |
| Negri, C | 1 |
| Cristina, S | 1 |
| Scoccia, S | 1 |
| De Maria, R | 1 |
| Fiocchi, R | 1 |
| Ferrazzi, P | 1 |
| Tindall, B | 1 |
| Hing, M | 1 |
| Edwards, P | 1 |
| Barnes, T | 1 |
| Mackie, A | 1 |
| Cooper, DA | 1 |
| Radentz, WH | 1 |
| Ray, TL | 1 |
| Santana, JL | 1 |
| Ramírez-Ronda, CH | 1 |
| Troke, PF | 1 |
| Andrews, RJ | 1 |
| Marriott, MS | 1 |
| Richardson, K | 1 |
| Le, CT | 1 |
| Dennis, M | 1 |
| Doble, N | 1 |
| Shaw, R | 1 |
| Rowland-Hill, C | 1 |
| Lush, M | 1 |
| Warnock, DW | 1 |
| Keal, EE | 1 |
10 reviews available for ketoconazole and Opportunistic Infections
| Article | Year |
|---|---|
[The subcutaneous mucormycosis due to Lichtheimia corymbifera: A case report in an immunocompetent child].
Topics: Antifungal Agents; Biopsy; Child; Diagnostic Errors; Edema; Humans; Immunocompetence; Itraconazole; | 2012 |
Spondylodiscitis due to an emergent fungal pathogen: Blastoschizomyces capitatus, a case report and review of the literature.
Topics: Aged; Amphotericin B; Antifungal Agents; Dipodascus; Discitis; Fluconazole; Humans; Itraconazole; Ke | 2009 |
Improved outcome of zygomycosis in patients with hematological diseases?
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspe | 2004 |
Oral candidal infections and antimycotics.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agen | 2000 |
[Choice and monitoring of the treatment of systemic mycoses. Value and limitations of in vitro tests].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Th | 1992 |
Diagnosis and treatment of oral candidosis.
Topics: Antifungal Agents; Candidiasis, Oral; Chronic Disease; Fluconazole; HIV Infections; Humans; Immune T | 1991 |
[Mycoses and adrenocortical function. New pathogenetic aspects of adrenal hypofunction].
Topics: Acquired Immunodeficiency Syndrome; Adrenal Cortex Hormones; Adrenal Glands; Adrenal Insufficiency; | 1991 |
Azoles and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Azoles; Fluconazole; Humans; Itraconazole; Ke | 1990 |
Opportunistic fungal infections in immunocompromised hosts.
Topics: Amphotericin B; Dermatomycoses; Flucytosine; Humans; Immunosuppression Therapy; Ketoconazole; Opport | 1989 |
Systemic candidiasis.
Topics: Amphotericin B; Candidiasis; Flucytosine; Humans; Immune Tolerance; Ketoconazole; Neoplasms; Opportu | 1989 |
4 trials available for ketoconazole and Opportunistic Infections
| Article | Year |
|---|---|
Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combinat | 1992 |
Opportunistic fungal infections in patients with acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis; Cryptococcosis; Double-Blind Met | 1992 |
Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV.
Topics: Antifungal Agents; Candidiasis; Candidiasis, Oral; Double-Blind Method; Esophageal Diseases; Female; | 1991 |
Low-dose zidovudine in children with an human immunodeficiency virus type 1 infection acquired in the perinatal period.
Topics: Acquired Immunodeficiency Syndrome; Child, Preschool; Drug Administration Schedule; Drug Tolerance; | 1991 |
39 other studies available for ketoconazole and Opportunistic Infections
| Article | Year |
|---|---|
Antifungal susceptibility and phenotypic characterization of oral isolates of a black fungus from a nasopharyngeal carcinoma patient under radiotherapy.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Carcinoma; Caspofungin; Chemoradiotherapy; Chemotherapy | 2015 |
Presumptive Nocardia spp. infection in a dog treated with cyclosporin and ketoconazole.
Topics: Animals; Antifungal Agents; Cyclosporine; Dermatitis, Atopic; Dogs; Female; Immunosuppression Therap | 2010 |
Pneumocystis pneumonia during medicamentous treatment of Cushing's syndrome--a description of two cases.
Topics: Adult; Cushing Syndrome; Etomidate; Female; Humans; Hydrocortisone; Ketoconazole; Male; Middle Aged; | 2011 |
[Nosocomial urinary infection due to Trichosporon asahii. First two cases in Chile].
Topics: Amphotericin B; Antifungal Agents; Chile; Communicable Diseases, Emerging; Cross Infection; Drug Res | 2003 |
Life-threatening Pneumocystis jiroveci pneumonia following treatment of severe Cushing's syndrome.
Topics: Cushing Syndrome; Disease Progression; Fatal Outcome; Female; Humans; Ketoconazole; Middle Aged; Mif | 2007 |
Disseminated opportunistic fungal disease in dogs: 10 cases (1982-1990).
Topics: Animals; Discitis; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Fungi; Itraconazole; Ketoc | 1995 |
Ketoconazole in aspergillosis.
Topics: Aspergillosis; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Ketoconazole; Ki | 1994 |
Cutaneous alternariosis after renal transplantation.
Topics: Administration, Cutaneous; Alternaria; Dermatomycoses; Female; Humans; Ketoconazole; Kidney Transpla | 1995 |
Successful treatment of simultaneous pulmonary Pseudallescheria boydii and Aspergillus terreus infection with oral itraconazole.
Topics: Administration, Oral; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Bone Marrow Transplantat | 1993 |
Cutaneous lesions due to Pleurophoma (Phoma) complex.
Topics: Adult; Antifungal Agents; Dermatomycoses; Facial Dermatoses; Female; Humans; Ketoconazole; Mitospori | 1996 |
Cutaneous hyalohyphomycosis caused by Fusarium solani in a loggerhead sea turtle (Caretta caretta L.).
Topics: Administration, Topical; Animals; Antifungal Agents; Dermatomycoses; Drug Resistance, Microbial; Fus | 1997 |
Cutaneous infection due to acremonium.
Topics: Acremonium; Aged; Antifungal Agents; Dermatomycoses; Fatal Outcome; Humans; Immunocompromised Host; | 1998 |
Drugs for treatment of fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole | 1992 |
Maintenance itraconazole for visceral leishmaniasis in HIV infection.
Topics: Adult; Antifungal Agents; Female; HIV Infections; Humans; Itraconazole; Ketoconazole; Leishmaniasis, | 1992 |
Penicillium marneffei infection in patients infected with human immunodeficiency virus.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; HIV Infections; Humans; Itraconazole; Ketoconazole | 1992 |
Phaeohyphomycosis caused by Bipolaris spicifera: an informative case.
Topics: Adult; Brain Abscess; Female; Humans; Ketoconazole; Maxillary Sinusitis; Mitosporic Fungi; Mycoses; | 1992 |
Eosinophilic pustular folliculitis in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Eosinophilia; Folliculitis; Humans; Ketoconazole; Malasse | 1992 |
Disseminated histoplasmosis in an AIDS patient treated with itraconazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Blood; Histoplasma; Histoplasmosis; Hu | 1991 |
[Mycoses as opportunistic infections in AIDS patients].
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; H | 1991 |
[Visceral leishmaniasis with partial response to ketoconazole in a patient with positive antibodies to the human immunodeficiency virus].
Topics: Adult; Chronic Disease; HIV Infections; HIV Seropositivity; HIV-1; Humans; Ketoconazole; Leishmanias | 1991 |
Resolution of microsporidial epithelial keratopathy in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Animals; Antifungal Agents; Corneal Diseases; Cryptococco | 1991 |
Disseminated histoplasmosis in AIDS patients in Maryland.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Amphotericin B; Female; Histoplasma; Histoplasmosis | 1991 |
Opportunistic infections of the esophagus not responding to oral systemic antifungals in patients with AIDS: their frequency and treatment.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Administration, Oral; Adult; Amphotericin B; Antifung | 1991 |
[Trichosporon beigelii infection in immunodeficient patients].
Topics: Adult; Antifungal Agents; Azoles; Dermatomycoses; Humans; Immunologic Deficiency Syndromes; Ketocona | 1990 |
[Aspergillus mastoiditis in infected granulomatosis--a case report].
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Child; Combined Modality Therapy; Granuloma | 1990 |
Itraconazole in opportunistic mycoses: cryptococcosis and aspergillosis.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus; | 1990 |
Prophylaxis of fungal infections with itraconazole in immunocompromised cancer patients.
Topics: Adult; Aged; Antifungal Agents; Female; Humans; Immune Tolerance; Itraconazole; Ketoconazole; Male; | 1990 |
Lymphomatoid granulomatosis presenting as ulcerodestructive gastrointestinal tract lesions in patients with human immunodeficiency virus infection. A new association.
Topics: Acquired Immunodeficiency Syndrome; Adult; Colonic Diseases; Female; Humans; Interferon Type I; Keto | 1990 |
Sinus and nasal manifestations of the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Anti-Bacterial Agents; HIV Seropositivity; Human | 1990 |
Stable human immunodeficiency virus encephalopathy in two infants receiving early intravenous gammaglobulin plus antimicrobial prophylaxis.
Topics: Acquired Immunodeficiency Syndrome; Brain Diseases; Drug Combinations; Drug Therapy, Combination; HI | 1989 |
[Cryptococcosis of the skin].
Topics: Cryptococcosis; Cryptococcus neoformans; Dermatomycoses; Female; Humans; Itraconazole; Ketoconazole; | 1989 |
Experience with itraconazole in cryptococcosis and aspergillosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Cryptoc | 1989 |
Severe clinical manifestations of primary HIV infection.
Topics: Adult; Candidiasis; CD4-Positive T-Lymphocytes; Esophageal Diseases; HIV Infections; Humans; Ketocon | 1989 |
Itraconazole as maintenance treatment for cryptococcal meningitis in the acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Cryptococcosis; Humans; Itraconazole; Ketocon | 1988 |
[The pregnant woman infected with the human immunodeficiency virus: recommendations for her management].
Topics: Acquired Immunodeficiency Syndrome; Candidiasis; Cytomegalovirus Infections; Female; Humans; Ketocon | 1988 |
Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus | 1987 |
Adrenal mass in an immunocompromised man.
Topics: Abscess; Adrenal Gland Diseases; Amphotericin B; Aspergillosis; Aspergillus fumigatus; Diagnosis, Di | 1988 |
Drugs for treatment of deep fungal infection.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Flucytosine; Humans; Ketoconazole; Mycoses; Op | 1988 |
Pharmacokinetic study of the interaction between rifampicin and ketoconazole.
Topics: Drug Interactions; Humans; Ketoconazole; Male; Opportunistic Infections; Rifampin | 1988 |